Erratum: YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition (Gut (2021) 70 (55-60) DOI: 10.1136/gutjnl-2019-319748)

Research output: Contribution to journalComment/debatepeer-review

Abstract

In figure 1C upper left panel was double stained YAP1 and immune marker CD45 in IP-013 case as one of the representative cases indicating that YAP1 was enriched in tumour cells but not in immune CD45+ cells. The revised figure 1C should be: (Figure Presented) In figure 1C upper left panel was double stained YAP1 and immune marker CD45 in IP-013 case as one of the representative cases indicating that YAP1 was enriched in tumour cells but not in immune CD45+ cells. The revised figure 1C should be: Table 2B, there is an error in the number of PC cases stained for equal expression of YAP1 and EpCAM in patients’ samples and should be 47(38%) not 55 (45%). The correct table in figure 2 should be: (Figure Presented). Another error was noted in figure 6D,G the wrong image was mistakenly placed for GA070716 case in figure 6D lower left panel. The correct image for GA070716 should be: (Figure Presented).

Original languageEnglish (US)
Article numbere3
JournalGut
Volume70
Issue number5
DOIs
StatePublished - May 1 2021

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Erratum: YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition (Gut (2021) 70 (55-60) DOI: 10.1136/gutjnl-2019-319748)'. Together they form a unique fingerprint.

Cite this